Bollywood actor Manoj Bajpayee spoke about being part of the upcoming documentary 'The Vial' in which he will be narrating the story of the Covid-19 vaccination programme in India. He said that it is a tribute to healthcare...
iNCOVACC is the world's first intranasal vaccine for COVID to receive approval for the primary two-dose schedule, and as a heterologous booster dose. Earlier this month, Bharat Biotech received approval from the Central...
The company sources said Bharat Biotech is currently holding discussions with international “potential partners” who have approached the company for manufacturing and distribution of the intranasal vaccine globally.
On whether Bharat Biotech is looking at exporting the vaccine, he said some countries and international agencies are approaching the company for the intra-nasal vaccine. iNCOVACC is also the world's first intranasal COVID-19...
The nasal vaccine BBV154 received approval of the Drugs Controller General of India in November for restricted use in an emergency situation for those above 18 as a heterologous booster dose.
The deal has been approved under the green channel route, wherein a transaction which does not raise any risk of an appreciable adverse effect on competition is deemed to be approved on it being intimated to the competition...
Krishna Ella, chairman and managing director of Bharat Biotech, announced on Saturday that the company would launch the first intranasal COVID-19 vaccine in India on January 26.
The Union government was responding to petition filed by parents of two women who allegedly died after receiving Covishield vaccines, as per reports.
Refuting some media reports around the approvals for Covaxin, the vaccine maker said it condemns the "targeted narrative" against the vaccine put forth by a...
India's coronavirus vaccination programme began on January 16, 2021. Lauding vaccine makers Serum Institute of India, Bharat Biotech, Biological E and Zydus...
An analysis by Florida government found an 84% increase in heart-related deaths among males aged 18-39 within 28 days following Covid-19 mRNA vaccination.
Bharat Biotech's iNCOVACC has received Emergency Use approval from the Drugs Controller General of India, making it the world's first intransal vaccine to be...
.jpg)
The Bharat Biotech's intranasal Covid-19 vaccine was tested on around 4,000 volunteers with no side effects or adverse reactions.
Nigeria currently accounts for 14 per cent of all childhood rotavirus deaths globally, making it the country with the second-highest number of rotavirus deaths...
Vaccine manufacturer Bharat Biotech is expecting to receive clearance for its intranasal covid-19 vaccine in the month of August.
NTAGI's Standing Technical Sub-Committee (STSC), however, couldn’t arrive at a decision on introducing Corbevax and Covaxin in the vaccination programme.
FDA had earlier implemented a temporary pause on Covaxin trials, following the WHO's observations on Covaxin manufacturing plants in India.
Although WHO maintained that the vaccine is effective and there is no safety concern, it has recommended that countries using the vaccine take action as...
Bharat Biotech's Covaxin cleared for 6-12 age group by drugs regulator DCGI, as per media reports
The company said it has received funding to initiate the Phase I and Phase II trials of an indigenous affordable Receptor-Binding Domain (RBD) based vaccine...
Vaccine majors SII and Bharat Biotech on Saturday said they have decided to cut the prices of the precaution dose of their respective COVID-19 vaccines to Rs...
Around 96 per cent of all those above 15 years of age in India have so far received at least one vaccine dose.
The study by the ICMR and Covaxin manufacturer Bharat Biotech was conducted in January and the findings were published in the Journal of Travel Medicine on...
The WHO asked countries that have received the vaccine to take appropriate actions, according to the statement, but did not specify what the appropriate...
The WHO said the Bharat Biotech vaccine is effective and no safety concerns exist, but the suspension of production for export will result in the interruption...
